Logo of eidLink to Publisher's site
Emerg Infect Dis. 2000 Sep-Oct; 6(5): 481–486.
PMCID: PMC2627967

Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan.

Abstract

From 1996 to 1999, 17 culture-documented systemic infections due to novel, atypical strains of Chryseobacterium meningosepticum occurred in two newborns and 15 immunocompromised patients in a medical center in Taiwan. All clinical isolates, which were initially misidentified as Aeromonas salmonicida by an automated bacterial identification system, were resistant to a number of antimicrobial agents. The isolates were characterized as atypical strains of C. meningosepticum by complete biochemical investigation, 16S rRNA gene sequence analysis, cellular fatty acid analysis, and random amplified polymorphic DNA fingerprinting (RAPD). This is the first report of a cluster of atypically variant strains of C. meningosepticum, which may be an emerging pathogen in newborns and the immunocompromised.

Full Text

The Full Text of this article is available as a PDF (77K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • KING EO. Studies on a group of previously unclassified bacteria associated with meningitis in infants. Am J Clin Pathol. 1959 Mar;31(3):241–247. [PubMed]
  • Maderazo EG, Bassaris HP, Quintiliani R. Flavobacterium meningosepticum meningitis in a newborn infant. Treatment with intraventricular erythromycin. J Pediatr. 1974 Nov;85(5):675–676. [PubMed]
  • Thong ML, Puthucheary SD, Lee EL. Flavobacterium meningosepticum infection: an epidemiological study in a newborn nursery. J Clin Pathol. 1981 Apr;34(4):429–433. [PMC free article] [PubMed]
  • Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) 1997 Jan;76(1):30–41. [PubMed]
  • Werthamer S, Weiner M. Subacute bacterial endocarditis due to Flavobacterium meningosepticum. Am J Clin Pathol. 1972 Mar;57(3):410–412. [PubMed]
  • Ursing J, Bruun B. Genetic heterogeneity of Flavobacterium meningosepticum demonstrated by DNA-DNA hybridization. Acta Pathol Microbiol Immunol Scand B. 1987 Feb;95(1):33–39. [PubMed]
  • Colding H, Bangsborg J, Fiehn NE, Bennekov T, Bruun B. Ribotyping for differentiating Flavobacterium meningosepticum isolates from clinical and environmental sources. J Clin Microbiol. 1994 Feb;32(2):501–505. [PMC free article] [PubMed]
  • Welch DF. Applications of cellular fatty acid analysis. Clin Microbiol Rev. 1991 Oct;4(4):422–438. [PMC free article] [PubMed]
  • Husson MO, Izard D, Bouillet L, Leclerc H. Comparative in-vitro activity of ciprofloxacin against non-fermenters. J Antimicrob Chemother. 1985 Apr;15(4):457–462. [PubMed]
  • Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother. 1997 Dec;41(12):2738–2741. [PMC free article] [PubMed]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...